Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,348 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reply by Authors.
Farolfi A, Gafita A, Calais J, Eiber M, Afshar-Oromieh A, Spohn F, Barbato F, Weber M, Ilhan H, Cervati V, Wetter A, Hadaschik B, Briganti A, Walz J, Pianori D, Fanti S, Haberkorn U, Herrmann K, Fendler WP. Farolfi A, et al. Among authors: herrmann k. J Urol. 2019 Dec;202(6):1181. doi: 10.1097/01.JU.0000582680.86998.12. Epub 2019 Sep 16. J Urol. 2019. PMID: 31524577 No abstract available.
The sensitivity of [11C]choline PET/CT to localize prostate cancer depends on the tumor configuration.
Souvatzoglou M, Weirich G, Schwarzenboeck S, Maurer T, Schuster T, Bundschuh RA, Eiber M, Herrmann K, Kuebler H, Wester HJ, Hoefler H, Gschwend J, Schwaiger M, Treiber U, Krause BJ. Souvatzoglou M, et al. Among authors: herrmann k. Clin Cancer Res. 2011 Jun 1;17(11):3751-9. doi: 10.1158/1078-0432.CCR-10-2093. Epub 2011 Apr 14. Clin Cancer Res. 2011. PMID: 21493868
Diagnostic efficacy of [11C]choline positron emission tomography/computed tomography compared with conventional computed tomography in lymph node staging of patients with bladder cancer prior to radical cystectomy.
Maurer T, Souvatzoglou M, Kübler H, Opercan K, Schmidt S, Herrmann K, Stollfuss J, Weirich G, Haller B, Gschwend JE, Schwaiger M, Krause BJ, Treiber U. Maurer T, et al. Among authors: herrmann k. Eur Urol. 2012 May;61(5):1031-8. doi: 10.1016/j.eururo.2011.12.009. Epub 2011 Dec 14. Eur Urol. 2012. PMID: 22196847
Impact of 11C-choline PET/CT on clinical decision making in recurrent prostate cancer: results from a retrospective two-centre trial.
Ceci F, Herrmann K, Castellucci P, Graziani T, Bluemel C, Schiavina R, Vollmer C, Droll S, Brunocilla E, Mazzarotto R, Buck AK, Fanti S. Ceci F, et al. Among authors: herrmann k. Eur J Nucl Med Mol Imaging. 2014 Dec;41(12):2222-31. doi: 10.1007/s00259-014-2872-x. Epub 2014 Aug 15. Eur J Nucl Med Mol Imaging. 2014. PMID: 25182750
PET response criteria in solid tumors predicts progression-free survival and time to local or distant progression after chemotherapy with regional hyperthermia for soft-tissue sarcoma.
Fendler WP, Lehmann M, Todica A, Herrmann K, Knösel T, Angele MK, Dürr HR, Rauch J, Bartenstein P, Cyran CC, Hacker M, Lindner LH. Fendler WP, et al. Among authors: herrmann k. J Nucl Med. 2015 Apr;56(4):530-7. doi: 10.2967/jnumed.114.152462. Epub 2015 Feb 26. J Nucl Med. 2015. PMID: 25722445 Free article.
Synthesis and preclinical evaluation of an Al18F radiofluorinated GLU-UREA-LYS(AHX)-HBED-CC PSMA ligand.
Boschi S, Lee JT, Beykan S, Slavik R, Wei L, Spick C, Eberlein U, Buck AK, Lodi F, Cicoria G, Czernin J, Lassmann M, Fanti S, Herrmann K. Boschi S, et al. Among authors: herrmann k. Eur J Nucl Med Mol Imaging. 2016 Nov;43(12):2122-2130. doi: 10.1007/s00259-016-3437-y. Epub 2016 Jun 22. Eur J Nucl Med Mol Imaging. 2016. PMID: 27329046 Free PMC article.
1,348 results